As much as I’m extreamly pissed off by this, I have to accept it. I will say that the HIV combo indecation was not exactly a good trial to get approved. We wanted a mono approval from the start. We got stuck with combo because the FDA wanted it first. The path to mono approval was very unclear. It could be that potential partners did not want to partner for one indecation while the company is selling the same drug for another indecation. We are now able to be looked at a all in partnership or buyout.